JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
ZSTK
ZeroStack Corp.
There isn't enough reported data to score ZSTK yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ZSTK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
ZSTK's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like ZSTK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
ZSTK PE Valuation
ZSTK has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ZSTK Forward outlook
There aren't enough analyst estimates for ZSTK to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus ZSTK down 165%.
ZSTK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$390.51 | +$207.12 |
| Q2 2023 | -$471.89 | +$114.27 |
| Q1 2023 | -$466.10 | -$75.87 |
| Q4 2022 | -$528.95 | -$173.32 |
ZSTK is still losing money, but less than at its worst: $390.51 per share over the past year, against $597.63 at its worst in late 2022.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over ZSTK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over ZSTK on profitability, with a higher operating margin.
ZSTK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.7M | -7.7% |
| Q1 2026 | $7.3M | -38% |
| Q4 2025 | $9.4M | -30% |
| Q3 2025 | $9.7M | -22% |
| Q2 2025 | $14.8M | -5.7% |
| Q1 2025 | $11.8M | -35% |
| Q4 2024 | $13.3M | -26% |
| Q3 2024 | $12.5M | -28% |
ZSTK's revenue has slid since its 2023 peak: $14M last quarter, down 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -177% | -160 points |
| Q1 2026 | -861% | -853 points |
| Q4 2025 | -1596% | -1551 points |
| Q3 2025 | -34% | -3.9 points |
| Q2 2025 | -17% | +5.2 points |
| Q1 2025 | -8.3% | +5.5 points |
| Q4 2024 | -45% | -3.4 points |
| Q3 2024 | -30% | -27 points |
ZSTK's operating margin was −177% last quarter, down 160 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over ZSTK on cash flow, with more consistent year-over-year improvement.
ZSTK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.4M | +$4.3M |
| Q1 2026 | -$3.8M | -$1.1M |
| Q4 2025 | -$3.2M | -$1.8M |
| Q3 2025 | $91K | +$2.2M |
| Q2 2025 | -$3M | -$2.7M |
| Q1 2025 | -$2.8M | -$1.3M |
| Q4 2024 | -$1.3M | -$253K |
| Q3 2024 | -$2.1M | -510% |
ZSTK's free cash flow was −$6M over the past year, against −$9M the year before. Free cash flow isn't a meaningful measure for financial services companies like ZSTK.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ZSTK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ZSTK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +64% | +69.4K shares |
| 1 year | +99% | +88.8K shares |
ZSTK has 178,000 diluted shares, up 99% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $5,000 |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
ZSTK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | -0.9x | Net Cash |
ZSTK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like ZSTK.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ZSTK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 11.0 | Oversold |
ZSTK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
ZSTK PE vs Financial Services Sector
ZSTK has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over ZSTK on trend strength, trading above more of its moving averages.
ZSTK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.58 | 30% below |
| 20 week MA | $3.32 | 24% below |
| 50 week MA | $5.44 | 54% below |
| 100 week MA | $14.8 | 83% below |
| 200 week MA | $53.8 | 95% below |
ZSTK is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over ZSTK on returns for 2026, with the stronger performance.
ZSTK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3,159.0 | $1,560.0 | -51% |
| 2022 | $1,560.0 | $189.5 | -88% |
| 2023 | $189.5 | $52.7 | -72% |
| 2024 | $52.7 | $39.8 | -24% |
| 2025 | $39.8 | $7.28 | -82% |
| 2026 YTD | $7.28 | $2.51 | -66% |
ZSTK has finished every year since 2021 lower, and it's down 66% so far in 2026.